BFRA News and Press, Biofrontera AG From 07/11/19

Leverkusen, Germany, July 11, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced the results of the Annual General Meeting held on 10 July 2019. The shareholders pre...

Leverkusen, Germany, July 09, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company” or the “Biofrontera-group”), an international biopharmaceutical company, today reports preliminary unaudited revenue for the first s...

Biofrontera AG (NASDAQ: BFRA ) announces that three board members intend to tender all of their shares to the partial tender offer by Maruho Deutschland GmbH. More news on: Biofrontera AG, Healthcare stocks news, Read more ...

The Management Board intends to tender all personally held Biofrontera AG shares to Maruho Deutschland GmbH The Management Board intends to help Maruho Deutschland GmbH to successfully complete its offer and underlines the importance of the strategic partnership Should Deutsche Bal...

Leverkusen, Germany, June 12, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced that Thomas Schaffer, Biofrontera’s Chief Financial Officer, is scheduled to ...

Nanoemulsion Starting out as a scientist in the investing world, I was always fascinated by the behind hidden technology. Especially for biotech, understanding the scientific platform is something crucial to succeed. Nanotechnology is, in general, the process of creating small size cryst...

Editor's note: Seeking Alpha is proud to welcome End On Equity as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more » Biofrontera ( BFR...

Leverkusen, Germany, June 04, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today announced that the agenda for the Annual General Meeting to be held on July 10, 2019 has been ...

Biofrontera AG (BFRA) Q1 2019 Results Earnings Conference Call May 29, 2019, 08:00 AM ET Company Participants Pamela Keck - Investor Relations Hermann Lübbert - Chief Executive Officer Christoph Dünwald - Chief Commercial Officer Thomas Schaffer - Chief Financial Offi...

Leverkusen, Germany, May 29, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, today reported its financial results for the first quarter ended March 31, 2019 and provided an updat...